GlassScriptPhysician profile
Juli A Johnson
NPI 1245404946
$336.60
in general payments reported to CMS, 2019-2025
11 companies · $197 in 2025
The $197 reported for 2025 was less than what a typical Oncology (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $263).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $58.52 · 2023: $48.93 · 2024: $32.46 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $197 · Education: $81.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.69 |
| Education | $81.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $105.69 | 2022-2025 | |
| Ipsen Biopharmaceuticals, INC | $32.46 | 2024 | Tazverik, Onivyde |
| Genzyme Corporation | $30.63 | 2025 | |
| Janssen Biotech, INC. | $28.05 | 2025 | Darzalex, Tecvayli, Talvey |
| Sumitomo Pharma America, INC. | $23.93 | 2023 | Orgovyx |
| Merck Sharp & Dohme LLC | $21.13 | 2025 | Keytruda Qlex, Keytruda |
| Stemline Therapeutics INC. | $20.81 | 2025 | Orserdu |
| Lilly USA, LLC | $20.37 | 2025 | Jaypirca, Verzenio |
| Alexion Pharmaceuticals, INC. | $19.61 | 2025 | Ultomiris |
| Abbvie INC. | $17.04 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.88 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juli Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.